🏅 FDA Orphan Designation

Revcovi

elapegademase-lvlr

Manufacturer: Chiesi USA Inc.

Indicated for:📚 Short-limb skeletal dysplasia with severe combined immunodeficiency

Indications & Usage

1 INDICATIONS AND USAGE REVCOVI is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. REVCOVI is a recombinant adenosine deaminase indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. ( 1 )

💙 Support Programs

View all →

Revcovi

Chiesi USA Inc.

Apply ↗

Revcovi

Leadiant

Copay card ↗Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.